Glenmark launches generic of Inlyta tablets for kidney cancer treatment in USGlenmark Pharmaceuticals Inc has announced the launch of Axitinib Tablets in the United States in two strengths. These tablets are a generi...
16 Nov, 2026, 12.36 PM IST
Sun Pharma eyes $4 billion loan for Organon buy, five banks likely to anchor refinancingSun Pharmaceutical Industries is gearing up to secure a substantial $4 billion syndicated loan aimed at refining its financial structure. T...
16 Nov, 2026, 08.21 AM IST
PM in Manila: Aligning act east, Indo-Pacific & MAHASAGAR policiesPrime Minister Narendra Modi will visit Manila for the ASEAN Summit, focusing on strengthening India's partnerships. The growing competitio...
14 Nov, 2026, 11.34 PM IST
Compulsory licensing of drugs only after exhausting all other measures: Department of Pharmaceuticals secretary Manoj JoshiThe government plans to address the high costs of innovative medicines by first negotiating prices. Compulsory licensing will be considered...
14 Nov, 2026, 12.59 AM IST
Blue Jet Healthcare evaluating Rs 500 crore investment in Andhra Pradesh API manufacturing facilityBlue Jet Healthcare is evaluating the acquisition of 50 acres of land in Andhra Pradesh for an API manufacturing facility. The company plan...
13 Nov, 2026, 05.21 PM IST
NPPA issues strict guidelines for trade margin rationalisation on 137 cancer drugs to benefit patientsThe National Pharmaceutical Pricing Authority has implemented strict monitoring of Trade Margin Rationalisation for certain anti-cancer dru...
13 Nov, 2026, 03.46 PM IST
PLI schemes achieve 76% of investment target, 64% of production goal: Niti AayogThe production-linked incentive (PLI) scheme has achieved 76% of its investment target and 64% of its production target, with electronics, ...
13 Nov, 2026, 12.57 AM IST
Lupin partner Sandoz launches RanluspecTM across Europe for retinal disease treatmentLupin Ltd has partnered with Sandoz to launch RanluspecTM, a biosimilar for Ranibizumab, across Europe. This launch will help to improve ac...
12 Nov, 2026, 12.21 PM IST
India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...
12 Nov, 2026, 11.25 AM IST
USFDA classifies Aurobindo Pharma's US facility as 'official action indicated'The facility belongs to Lannett Company LLC, a wholly owned step-down subsidiary of Aurobindo Pharma. The US Food and Drug Administration (...
11 Nov, 2026, 10.10 PM IST
Aurobindo Pharma arm gets 'Voluntary Action Indicated' classification for Telengana facility from USFDAFollowing an inspection from September 7 to September 15, 2026, the US FDA granted Apitoria Pharma, a subsidiary of Aurobindo Pharma, a Vol...
11 Nov, 2026, 02.22 PM IST
Drugmakers tap China AI app boom to reach doctors as crackdown upends marketingAs scrutiny intensifies, Chinese pharmaceutical companies are shifting gears toward digital marketing initiatives. Traditional face-to-face...
11 Nov, 2026, 12.35 PM IST
Government extends ₹2,700-crore PLI scheme for medical devices till 2035-36, eases eligibility normsThe government has extended the ₹2,700-crore production-linked incentive (PLI) scheme for domestic medical device manufacturing until 2035-...
11 Nov, 2026, 12.53 AM IST
Morepen Laboratories launches Desloratadine (Rx) generic drug product in US marketMorepen Laboratories has launched its prescription generic product Desloratadine in the United States market. This launch is managed throug...
09 Nov, 2026, 11.03 AM IST
Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...
07 Nov, 2026, 05.39 PM IST
Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 crGlenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from...
05 Nov, 2026, 08.08 PM IST
Bayer raises 2026 profit outlook on strong pharmaceuticals performanceBayer raised its 2026 profit outlook after its pharmaceuticals division delivered stronger-than-expected third-quarter sales. The German gr...
03 Nov, 2026, 01.50 PM IST